Cyanotech Corporation, which specialises in microalgae-based, high-value nutrition and health products, has announced its financial results for the first quarter of fiscal year 2013, ended June 30, 2012.
First Quarter 2013
|English: Spirulina (dietary supplement) tablets are made from cyanobacteria genus Arthrospira. (Photo credit: Wikipedia)|
For the first quarter of fiscal 2013 compared to the first quarter of fiscal 2012, revenues were $6,506,000 compared to $5,950,000, an increase of 9%. Gross profit was $2,574,000, with gross profit margin of 39.6%, compared to gross profit of $2,104,000 and gross profit margin of 35.4%. Net income was $493,000 or $0.08 per diluted share, compared to net income of $486,000 or $0.09 per diluted share.Read more...